Financing
Proceeds from Issuance of Commercial Paper
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025Feb 11, 2026
How to read this metric
Frequent or increasing issuance may signal a need for short-term liquidity, while consistent use indicates efficient management of working capital cycles.
Detailed definition
This represents cash raised through the issuance of short-term, unsecured promissory notes used to manage immediate work...
Peer comparison
Standard for large-cap companies with high credit ratings that utilize commercial paper markets for low-cost, short-term financing.
Metric ID:
financing_proceeds_from_issuance_of_commercial_paperHistorical Data
11 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.99B | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | -100.0% | — | — | — |
Range$0.00 – $2.99B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Proceeds from Issuance of Commercial Paper at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's proceeds from issuance of commercial paper?
- Bristol-Myers Squibb (BMY) reported proceeds from issuance of commercial paper of $0.00 in Q4 2025.
- What does proceeds from issuance of commercial paper mean?
- Cash received from issuing short-term debt instruments to cover immediate funding needs.